Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN

No-Receipt date 2025-01217 - 07/04/2025
No-Filing date 20250400729 - 07/04/2025
No-Granting date 3117973 - 15/04/2025
No-EPO application date 18786587.8 - 26/09/2018
No-EPO granting date 3687562 - 19/03/2025
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 4/2025 - 14/05/2025
Expiration date 27/09/2038
Kind of title Validation of European Patent
Legal status VALID
Priorities US201762563387 P26/09/2017/US
US201862616819 P12/01/2018/US
US201862625075 P01/02/2018/US
US201862639425 P06/03/2018/US
US201862654291 P06/04/2018/US
US201862691552 P28/06/2018/US
US201862716331 P08/08/2018/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/17
A61K 38/20
A61K 39/395
A61K 47/68
A61P 29/00
A61P 9/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1738944 REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROADTARRYTOWN, NY 10591 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4563842 TESSARI, EBEN
4563843 PAOLINI, JOHN

Representatives
CodeFirstnameSurnameAddressTownZip
3098ANNAGIAKOUMIALKAMENOUS 12-14ATHINA (ATTIKIS)10439

Contact
CodeFirstnameSurnameAddressTownZipCountry
8397ANDRONIKIMISIOUANALIPSEOS 23 KAI MARATHONOS 27VRILISSIA (ATTIKIS)15235 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015